All stock lists
Senti Biosciences Holdings, Inc. (NASDAQ:SNTI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.17-0.02 (-8.44%)
Insider Score
––Not scored
SNTI Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SNTI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 17.00 K | 16.00 K | 22.00 K | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 667.00 K | 0.00 | 893.00 K | 0.00 | 1.48 M | 0.00 |
| Gross Profit | -650.00 K | 16.00 K | -871.00 K | 0.00 | -1.48 M | 0.00 |
| SG&A Expense | 6.74 M | 5.76 M | 5.85 M | 5.75 M | 6.77 M | 6.42 M |
| R&D Expense | 7.77 M | 5.28 M | 7.76 M | 10.52 M | 9.80 M | 9.28 M |
| Operating Expenses | 13.84 M | 11.51 M | 12.71 M | 16.95 M | 15.32 M | 16.40 M |
| Operating Income | -14.49 M | -11.50 M | -13.58 M | -16.95 M | -16.80 M | -16.40 M |
| Pretax Income | -12.75 M | -4.22 M | -14.47 M | -18.13 M | -14.73 M | -14.11 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -12.75 M | -4.22 M | -14.47 M | -18.13 M | -14.73 M | -14.11 M |
| EPS (Basic) | -0.41 | -0.14 | -0.53 | -0.69 | -0.56 | -1.41 |
| EPS (Diluted) | -0.41 | -0.14 | -0.53 | -0.69 | -0.56 | -1.41 |
| Shares Outstanding | 31.14 M | 30.97 M | 22.48 M | 26.23 M | 26.08 M | 10.01 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.